266 related articles for article (PubMed ID: 21298051)
21. Phylodynamic profile of HIV-1 subtype B, CRF01_AE and the recently emerging CRF51_01B among men who have sex with men (MSM) in Singapore.
Ng KT; Ng KY; Khong WX; Chew KK; Singh PK; Yap JK; Tan MT; Leo YS; Laeyendecker O; Quinn TC; Kamarulzaman A; Tee KK; Ng OT
PLoS One; 2013; 8(12):e80884. PubMed ID: 24312505
[TBL] [Abstract][Full Text] [Related]
22. Primary drug resistance and transmission analysis of HIV-1 in acute and recent drug-naïve seroconverters in Singapore.
Lee CC; Sun YJ; Barkham T; Leo YS
HIV Med; 2009 Jul; 10(6):370-7. PubMed ID: 19490177
[TBL] [Abstract][Full Text] [Related]
23. Natural polymorphisms in HIV-1 CRF01_AE strain and profile of acquired drug resistance mutations in a long-term combination treatment cohort in northeastern China.
Sun Z; Ouyang J; Zhao B; An M; Wang L; Ding H; Han X
BMC Infect Dis; 2020 Feb; 20(1):178. PubMed ID: 32102660
[TBL] [Abstract][Full Text] [Related]
24. How soon after HIV seroconversion is antiretroviral therapy initiated? The UK Register of HIV Seroconverters Steering Committee.
AIDS; 1999 Jul; 13(10):1241-7. PubMed ID: 10416529
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 CRF01_AE strain is associated with faster HIV/AIDS progression in Jiangsu Province, China.
Chu M; Zhang W; Zhang X; Jiang W; Huan X; Meng X; Zhu B; Yang Y; Tao Y; Tian T; Lu Y; Jiang L; Zhang L; Zhuang X
Sci Rep; 2017 May; 7(1):1570. PubMed ID: 28484257
[TBL] [Abstract][Full Text] [Related]
26. Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study.
Lam EP; Moore CL; Gotuzzo E; Nwizu C; Kamarulzaman A; Chetchotisakd P; van Wyk J; Teppler H; Kumarasamy N; Molina JM; Emery S; Cooper DA; Boyd MA
AIDS Res Hum Retroviruses; 2016 Sep; 32(9):841-50. PubMed ID: 27346600
[TBL] [Abstract][Full Text] [Related]
27. Complex patterns of the HIV-1 epidemic in Kuala Lumpur, Malaysia: evidence for expansion of circulating recombinant form CRF33_01B and detection of multiple other recombinants.
Wang B; Lau KA; Ong LY; Shah M; Steain MC; Foley B; Dwyer DE; Chew CB; Kamarulzaman A; Ng KP; Saksena NK
Virology; 2007 Oct; 367(2):288-97. PubMed ID: 17604072
[TBL] [Abstract][Full Text] [Related]
28. Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria.
Ogoina D; Finomo F; Harry T; Inatimi O; Ebuenyi I; Tariladei WW; Afolayan AA
PLoS One; 2015; 10(5):e0125665. PubMed ID: 25933356
[TBL] [Abstract][Full Text] [Related]
29. Characterization of mutations in CRF01_AE virus isolates from antiretroviral treatment-naive and -experienced patients in Singapore.
Hsu LY; Subramaniam R; Bacheler L; Paton NI
J Acquir Immune Defic Syndr; 2005 Jan; 38(1):5-13. PubMed ID: 15608517
[TBL] [Abstract][Full Text] [Related]
30. Effects of HIV-1 genotype on baseline CD4+ cell count and mortality before and after antiretroviral therapy.
Cao Z; Li J; Chen H; Song C; Shen Z; Zhou X; Lan G; Zhu Q; Liang S; Xing H; Liao L; Feng Y; Shao Y; Ruan Y
Sci Rep; 2020 Sep; 10(1):15875. PubMed ID: 32985559
[TBL] [Abstract][Full Text] [Related]
31. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
32. Virological remission after antiretroviral therapy interruption in female African HIV seroconverters.
Gossez M; Martin GE; Pace M; Ramjee G; Premraj A; Kaleebu P; Rees H; Inshaw J; Stöhr W; Meyerowitz J; Hopkins E; Jones M; Hurst J; Porter K; Babiker A; Fidler S; Frater J;
AIDS; 2019 Feb; 33(2):185-197. PubMed ID: 30325764
[TBL] [Abstract][Full Text] [Related]
33. Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.
Touloumi G; Pantazis N; Chaix ML; Bucher HC; Zangerle R; Kran AM; Thiebaut R; Masquelier B; Kucherer C; Monforte Ad; Meyer L; Porter K;
PLoS One; 2013; 8(7):e71174. PubMed ID: 23936260
[TBL] [Abstract][Full Text] [Related]
34. The Molecular Epidemiological and Immunological Characteristics of HIV-1 CRF01_AE/B Recombinants in Nanjing, China.
Ge Y; Liu Y; Fu G; Lu J; Li X; Du G; Fei G; Wang Z; Li H; Li W; Wei P
Front Microbiol; 2022; 13():936502. PubMed ID: 35910646
[TBL] [Abstract][Full Text] [Related]
35. Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?
Jarrin I; Pantazis N; Dalmau J; Phillips AN; Olson A; Mussini C; Boufassa F; Costagliola D; Porter K; Blanco J; Del Amo J; Martinez-Picado J;
AIDS; 2015 Nov; 29(17):2323-33. PubMed ID: 26544704
[TBL] [Abstract][Full Text] [Related]
36. Activated PD-1+ CD4+ T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ART.
Eller MA; Hong T; Creegan M; Nau ME; Sanders-Buell E; Slike BM; Krebs SJ; Ratto-Kim S; McElrath MJ; Katabira ET; Bolton DL; Michael NL; Robb ML; Tovanabutra S; Baeten JM; Sandberg JK
AIDS; 2020 Feb; 34(2):197-202. PubMed ID: 31764072
[TBL] [Abstract][Full Text] [Related]
37. Decline of CD4⁺ T-cell count before start of therapy and immunological response to treatment in antiretroviral-naive individuals.
Mussini C; Cossarizza A; Sabin C; Babiker A; De Luca A; Bucher HC; Fisher M; Rezza G; Porter K; Dorrucci M;
AIDS; 2011 May; 25(8):1041-9. PubMed ID: 21412128
[TBL] [Abstract][Full Text] [Related]
38. High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland.
Kivelä PS; Krol A; Salminen MO; Geskus RB; Suni JI; Anttila VJ; Liitsola K; Zetterberg V; Miedema F; Berkhout B; Coutinho RA; Ristola MA
Scand J Infect Dis; 2005; 37(4):276-83. PubMed ID: 15871166
[TBL] [Abstract][Full Text] [Related]
39. Unique CRF01_AE Gag CTL epitopes associated with lower HIV-viral load and delayed disease progression in a cohort of HIV-infected Thais.
Mori M; Sriwanthana B; Wichukchinda N; Boonthimat C; Tsuchiya N; Miura T; Pathipvanich P; Ariyoshi K; Sawanpanyalert P
PLoS One; 2011; 6(8):e22680. PubMed ID: 21826201
[TBL] [Abstract][Full Text] [Related]
40. Coreceptor tropism determined by genotypic assay in HIV-1 circulating in Thailand, where CRF01_AE predominates.
Phuphuakrat A; Phawattanakul S; Pasomsub E; Kiertiburanakul S; Chantratita W; Sungkanuparph S
HIV Med; 2014 May; 15(5):269-75. PubMed ID: 24215399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
